Nukkleus (NASDAQ:DFNS) Stock Price Up 0.4% – Time to Buy?

Shares of Nukkleus Inc. (NASDAQ:DFNS) rose 0.4% during trading on Wednesday . The stock traded as high as $0.2823 and last traded at $0.2751. Approximately 1,622,538 shares traded hands during trading, a decline of 67% from the average daily volume of 4,876,915 shares. The stock had previously closed at $0.2740.

Analysts Set New Price Targets

DFNS has been the topic of several analyst reports. Wall Street Zen lowered shares of Nukkleus from a “hold” rating to a “sell” rating in a research report on Saturday, April 18th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Nukkleus in a research report on Monday, March 23rd. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

Nukkleus Stock Performance

The firm’s fifty day moving average price is $0.48 and its 200 day moving average price is $2.25. The company has a current ratio of 0.25, a quick ratio of 0.21 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $10.40 million, a price-to-earnings ratio of -0.09 and a beta of -6.00.

Nukkleus (NASDAQ:DFNS) last released its earnings results on Wednesday, May 20th. The company reported ($1.14) earnings per share (EPS) for the quarter. The business had revenue of $3.65 million for the quarter.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC increased its stake in Nukkleus by 193.7% in the fourth quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock valued at $503,000 after purchasing an additional 82,252 shares during the period. LPL Financial LLC acquired a new position in shares of Nukkleus during the fourth quarter worth about $120,000. Engineers Gate Manager LP acquired a new position in shares of Nukkleus during the fourth quarter worth about $96,000. UBS Group AG increased its stake in shares of Nukkleus by 23.3% during the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after acquiring an additional 15,223 shares during the period. Finally, Ausdal Financial Partners Inc. acquired a new position in shares of Nukkleus during the third quarter worth about $105,000. Institutional investors and hedge funds own 12.47% of the company’s stock.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.